Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
This study focused on the expression of mitochondrial serine hydroxymethyltransferase (SHMT2) in oral squamous cell carcinoma (OSCC) and its correlation with clinical traits and the prognosis of OSCC patients. Immunochemical staining and Western blotting were used to quantify the expression of SHMT2...
Main Authors: | Zhi-Zhong Wu, Shuo Wang, Qi-Chao Yang, Xiao-Long Wang, Lei-Lei Yang, Bing Liu, Zhi-Jun Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.588530/full |
Similar Items
-
Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer
by: Peng Zhang, et al.
Published: (2021-06-01) -
SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma
by: Weiyu Kong, et al.
Published: (2022-08-01) -
SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
by: Yongli Situ, et al.
Published: (2023-09-01) -
Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer
by: Jun Li, et al.
Published: (2023-04-01) -
SHMT2 Promotes Invasion and Migration of Breast Cancer Cells Through Binding to and Up-regulating HAX1
by: CHEN Qianzhi, et al.
Published: (2023-09-01)